The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis - PubMed (original) (raw)
Review
The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis
Mohammed S Razzaque et al. J Endocrinol. 2007 Jul.
Abstract
Normal mineral ion homeostasis is tightly controlled by numerous endocrine factors that coordinately exert effects on intestine, kidney, and bone to maintain physiological balance. The importance of the fibroblast growth factor (FGF)-23-klotho axis in regulating mineral ion homeostasis has been proposed from recent research observations. Experimental studies suggest that 1) FGF23 is an important in vivo regulator of phosphate homeostasis, 2) FGF23 acts as a counter regulatory hormone to modulate the renal 1alpha-hydroxylase and sodium-phosphate cotransporter activities, 3) there is a trend of interrelationship between FGF23 and parathyroid hormone activities, 4) most of the FGF23 functions are conducted through the activation of FGF receptors, and 5) such receptor activation needs klotho, as a cofactor to generate downstream signaling events. These observations clearly suggest the emerging roles of the FGF23-klotho axis in maintaining mineral ion homeostasis. In this brief article, we will summarize how the FGF23-klotho axis might coordinately regulate normal mineral ion homeostasis, and how their abnormal regulation could severely disrupt such homeostasis to induce disease pathology.
Conflict of interest statement
The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
Figures
Figure 1
Schematic diagram showing the structure of full-length FGF23 protein (A) with its putative signal peptide (aa 1–24), the amino terminal of FGF23 (aa 25–179) has the homologous region to other known FGFs; the carboxy terminal of FGF23 (aa 180–251) might have possible klotho-interacting site. Moreover, aa 176–179 represents the subtilisin-like cleavage site, where full-length FGF23 protein is cleaved into the smaller 18 kDa amino-terminal and the 12 kDa carboxy-terminal fragments (B). Mutations in 176R and 179R have been reported in patients with ADHR, whereas mutations in 71S, 96M, and 129S have been associated with patients affected by FTC. FGF23 has been shown to be _O_-glycosylated by the enzyme GALNT3 and the major glycosylation site is believed to be 178T, as shown in the diagram. Klotho protein (C) is composed of 1014 amino acids, and possesses a putative signal sequence (SS) at its N-terminus and a putative transmembrane domain (TM) with a short cytoplasmic domain (CD) at the C-terminus. The extracellular domain of the klotho protein consists of two internal repeats (KL1 and KL2) that share sequence homology to the _β_-glucosidase.
Figure 2
Altered mineralization in bone and kidney of Fgf23 knockout (_Fgf23_−/−) mice. Note abnormal nodular lesions (arrow) in the ribs of Fgf23−/− mice, compared with control (A). Histomorphometric analysis on methyl methacrylate sections, stained with toluidine blue and von Kossa’s stains, shows increased mineral deposition (black) in the mutant ribs (asterisk; B). It is worth to mention that in _Fgf23_−/− mice, skeletal mineralization has heterogeneous distribution, where increased mineral deposition is also accompanied with unmineralized osteoid (light blue) formation (B). Extensive soft tissue mineralization is a characteristic feature in _Fgf23_−/− mice, as shown here in the kidney (C).
Figure 3
Schematic outline of FGF23–FGFR interactions. Signaling of FGF23–FGFR involves klotho as a cofactor to induce such downstream signaling molecules as Erk1/2, which could influence the activation of Egr-1. FGF23 also induces Nab-2 (Fukuda et al. 2007), specific corepressor of Egr-1 that could suppress the transcriptional activity of Egr-1, and thereby establish a negative feedback loop to regulate physiological activities of FGF23.
Similar articles
- FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?
Razzaque MS. Razzaque MS. Am J Physiol Renal Physiol. 2009 Mar;296(3):F470-6. doi: 10.1152/ajprenal.90538.2008. Epub 2008 Nov 19. Am J Physiol Renal Physiol. 2009. PMID: 19019915 Free PMC article. Review. - Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
Ohnishi M, Razzaque MS. Ohnishi M, et al. Contrib Nephrol. 2013;180:1-13. doi: 10.1159/000346774. Epub 2013 May 3. Contrib Nephrol. 2013. PMID: 23652546 Review. - Pleiotropic Actions of FGF23.
Erben RG. Erben RG. Toxicol Pathol. 2017 Oct;45(7):904-910. doi: 10.1177/0192623317737469. Epub 2017 Nov 2. Toxicol Pathol. 2017. PMID: 29096595 Free PMC article. Review. - Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M, Komaba H, Fukagawa M. Koizumi M, et al. Contrib Nephrol. 2013;180:110-23. doi: 10.1159/000346791. Epub 2013 May 3. Contrib Nephrol. 2013. PMID: 23652554 Review. - The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.
Razzaque MS. Razzaque MS. Nat Rev Endocrinol. 2009 Nov;5(11):611-9. doi: 10.1038/nrendo.2009.196. Nat Rev Endocrinol. 2009. PMID: 19844248 Free PMC article. Review.
Cited by
- PKC regulates αKlotho gene expression in MDCK and NRK-52E cells.
Wolf L, Vogt J, Alber J, Franjic D, Feger M, Föller M. Wolf L, et al. Pflugers Arch. 2024 Jan;476(1):75-86. doi: 10.1007/s00424-023-02863-3. Epub 2023 Sep 29. Pflugers Arch. 2024. PMID: 37773536 Free PMC article. - Significance of changes in FGF23 levels in childhood primary nephrotic syndrome and children who progress to end‑stage renal disease.
Liu D, Yang F, Zhang S, Guo Z, Peng S. Liu D, et al. Exp Ther Med. 2023 Jun 30;26(2):390. doi: 10.3892/etm.2023.12089. eCollection 2023 Aug. Exp Ther Med. 2023. PMID: 37456167 Free PMC article. - Possible contribution of phosphate to the pathogenesis of chronic kidney disease in dolphins.
Jahan N, Ohsaki H, Kaneko K, Rahman A, Nishiyama T, Koizumi M, Yamanaka S, Kitada K, Sugiura Y, Matsui K, Yokoo T, Hamano T, Kuro-O M, Itou T, Suzuki M, Ueda K, Nishiyama A. Jahan N, et al. Sci Rep. 2023 Mar 29;13(1):5161. doi: 10.1038/s41598-023-32399-6. Sci Rep. 2023. PMID: 36991108 Free PMC article. - Phosphate Burden and Organ Dysfunction.
Mironov N, Atfi A, Razzaque MS. Mironov N, et al. Front Aging. 2022 Jul 14;3:890985. doi: 10.3389/fragi.2022.890985. eCollection 2022. Front Aging. 2022. PMID: 35928251 Free PMC article. No abstract available. - Non-classical Vitamin D Actions for Renal Protection.
Dusso AS, Bauerle KT, Bernal-Mizrachi C. Dusso AS, et al. Front Med (Lausanne). 2021 Dec 7;8:790513. doi: 10.3389/fmed.2021.790513. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34950686 Free PMC article. Review.
References
- ADHR_Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR consortium. Nature Genetics. 2000;26:345–348. - PubMed
- Bai X, Miao D, Li J, Goltzman D, Karaplis AC. Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology. 2004;145:5269–5279. - PubMed
- Benet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM. FGF23 is processed by proprotein convertases but not by PHEX. Bone. 2004;35:455–462. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources